N
CNTB

Nuveen’s Connect Biopharma Holdings CNTB Stock Holding History

Nuveen’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1K Buy
+19,773
New +$47.9K ﹤0.01% 3724

Other funds holding CNTB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Nuveen's CNTB Position: Q2 2026 in Review

Nuveen opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 19,773 shares worth $47.1K. The stake represents ﹤0.01% of the portfolio and ranks #3724 among its holdings.

19 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Nuveen held 19,773 shares of Connect Biopharma Holdings worth $47.1K as of Q2 2026.
  • Connect Biopharma Holdings was a new Nuveen position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3724 holding.
  • 19 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.